Cargando…
Surveillance following breast cancer: is it cost-effective?
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978822/ http://dx.doi.org/10.1186/bcr2658 |
_version_ | 1782191298975891456 |
---|---|
author | Ternent, L MacLennan, G Heys, SD Gilbert, F Vale, L |
author_facet | Ternent, L MacLennan, G Heys, SD Gilbert, F Vale, L |
author_sort | Ternent, L |
collection | PubMed |
description | |
format | Text |
id | pubmed-2978822 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-29788222010-11-13 Surveillance following breast cancer: is it cost-effective? Ternent, L MacLennan, G Heys, SD Gilbert, F Vale, L Breast Cancer Res Poster Presentation BioMed Central 2010 2010-10-25 /pmc/articles/PMC2978822/ http://dx.doi.org/10.1186/bcr2658 Text en Copyright ©2010 Ternent et al; licensee BioMed Central Ltd. |
spellingShingle | Poster Presentation Ternent, L MacLennan, G Heys, SD Gilbert, F Vale, L Surveillance following breast cancer: is it cost-effective? |
title | Surveillance following breast cancer: is it cost-effective? |
title_full | Surveillance following breast cancer: is it cost-effective? |
title_fullStr | Surveillance following breast cancer: is it cost-effective? |
title_full_unstemmed | Surveillance following breast cancer: is it cost-effective? |
title_short | Surveillance following breast cancer: is it cost-effective? |
title_sort | surveillance following breast cancer: is it cost-effective? |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978822/ http://dx.doi.org/10.1186/bcr2658 |
work_keys_str_mv | AT ternentl surveillancefollowingbreastcancerisitcosteffective AT maclennang surveillancefollowingbreastcancerisitcosteffective AT heyssd surveillancefollowingbreastcancerisitcosteffective AT gilbertf surveillancefollowingbreastcancerisitcosteffective AT valel surveillancefollowingbreastcancerisitcosteffective |